Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status
Sami Hraiech,1,2 Fabienne Brégeon,1,3 Jean-Marc Rolain1 1Institut Hospitalo-Universitaire Méditerranée Infection, URMITE CNRS IRD INSERM UMR 7278, 2Réanimation Médicale – Détresses Respiratoires et Infections Sévères, APHM, CHU Nord, 3Service d’Explorations Fonctionnelles Respiratoires, APHM, CHU No...
Saved in:
Main Authors: | Hraiech S (Author), Brégeon F (Author), Rolain JM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Animal models of polymicrobial pneumonia
by: Hraiech S, et al.
Published: (2015) -
Ticarcillin Hypersusceptibility in Pseudomonas Aeruginosa in Cystic Fibrosis
by: IT Hettiarachchi, et al.
Published: (2017) -
Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of <i>Pseudomonas aeruginosa</i> Infection
by: Isaac Martin, et al.
Published: (2023) -
Inflammatory Markers in Cystic Fibrosis Patients with Lung Pseudomonas Aeruginosa Infection
by: A. L. Pukhalsky, et al.
Published: (1999) -
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
by: Zahra Chegini, et al.
Published: (2020)